Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR
Description
About Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR
The Candidatus Gracilibacteria bacterium Peroxiredoxin Peptide (IEDB: 844711) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Peroxiredoxin Peptide, H-GTFIIDPAAVIR-OH (Uniprot: Genbank: MDD2745546.1 ) from JPT is produced under strict quality control and quality management.
Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR - Specifications
- Peptide sequence: H-GTFIIDPAAVIR-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): non-Hodgkin lymphoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR
References:
Read References with JPT’s Antigen Peptides
Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR has been described in:
Membranal and Blood-Soluble HLA Class II Peptidome Analyses Using Data-Dependent and Independent Acquisition., Proteomics, 2018 (PMID: 29314611)
Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors., Mol Cell Proteomics, 2020 (PMID: 32357974)
Documentation
Documentation for Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR
Properties
Properties of Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | non-Hodgkin lymphoma |
Layout: | Freeze-dried in glass vial |
Organism: | Candidatus Gracilibacteria bacterium |
Protein Name: | Peroxiredoxin |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Candidatus Gracilibacteria bacterium peroxiredoxin, GTFIIDPAAVIR
Information | Values |
---|---|
Sequence: | H-GTFIIDPAAVIR-OH |
Specifications: | 12mer peptide as TFA salt |